Ozempic Maker Novo Nordisk Faces Board Shakeup

benzinga.com/markets/large-cap/25/11/48863530/ozempic-maker-novo-nordisk-faces-board-shakeup

On Friday, Novo Nordisk A/S' (NYSE:NVO) board director Mikael Dolsten said he will not seek election to the Board of Directors at the upcoming extraordinary general meeting on 14 November 2025.
Dolsten, who most recently served as the Head of R&D at Pfizer (NYSE:PFE), informed Novo…

This story appeared on benzinga.com, 2025-11-14 14:12:27.
The Entire Business World on a Single Page. Free to Use →